APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drug Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Contraceptive Drug Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173901340328 December 2025196 pages

Choose your research edition.

Industry ResearchContraceptive Drug Eluting Devices Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drug Eluting Devices Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Contraceptive Drug Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drug Eluting Devices Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drug Eluting Devices Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Contraceptive Drug Eluting Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Contraceptive Drug Eluting Devices include CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences and Mona Lisa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contraceptive Drug Eluting Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptive Drug Eluting Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptive Drug Eluting Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptive Drug Eluting Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptive Drug Eluting Devices Segment by Company

CooperSurgical

Egemen International

ERENLER MEDIKAL

Gyneas

Laboratoire CCD

Medical Engineering Corporation

Melbea

Meril Life Sciences

Mona Lisa

Pregna

Pregna International

Prosan International

Rongbo Medical

SMB Corporation of India

AbbVie

Bayer

Contraceptive Drug Eluting Devices Segment by Type

Non-biodegradable

Biodegradable

Contraceptive Drug Eluting Devices Segment by Application

Subcutaneously

Uterus

Contraceptive Drug Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drug Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drug Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drug Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptive Drug Eluting Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contraceptive Drug Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Contraceptive Drug Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Contraceptive Drug Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Contraceptive Drug Eluting Devices Industry Trends Table 2. Contraceptive Drug Eluting Devices Industry Drivers Table 3. Contraceptive Drug Eluting Devices Industry Opportunities and Challenges Table 4. Contraceptive Drug Eluting Devices Industry Restraints Table 5. Global Contraceptive Drug Eluting Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Contraceptive Drug Eluting Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Contraceptive Drug Eluting Devices Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers Table 9. Global Contraceptive Drug Eluting Devices Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Contraceptive Drug Eluting Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Contraceptive Drug Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Contraceptive Drug Eluting Devices Manufacturers, Product Type & Application Table 13. Global Contraceptive Drug Eluting Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptive Drug Eluting Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Non-biodegradable Table 17. Major Manufacturers of Biodegradable Table 18. Global Contraceptive Drug Eluting Devices Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 20. Global Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 21. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2026) Table 22. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2027-2032) Table 23. Global Contraceptive Drug Eluting Devices Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (K Units) Table 25. Global Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (K Units) Table 26. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2026) Table 27. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Subcutaneously Table 29. Major Manufacturers of Uterus Table 30. Global Contraceptive Drug Eluting Devices Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 32. Global Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 33. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2026) Table 34. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2027-2032) Table 35. Global Contraceptive Drug Eluting Devices Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (K Units) Table 37. Global Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (K Units) Table 38. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2026) Table 39. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2027-2032) Table 40. Global Contraceptive Drug Eluting Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Contraceptive Drug Eluting Devices Sales by Region (2021-2026) & (K Units) Table 42. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2021-2026) Table 43. Global Contraceptive Drug Eluting Devices Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Contraceptive Drug Eluting Devices Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 47. North America Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 48. Europe Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 50. Europe Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 57. Global Contraceptive Drug Eluting Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Contraceptive Drug Eluting Devices Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Contraceptive Drug Eluting Devices Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021-2026) Table 61. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2027-2032) Table 62. CooperSurgical Company Information Table 63. CooperSurgical Business Overview Table 64. CooperSurgical Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio Table 66. CooperSurgical Recent Development Table 67. Egemen International Company Information Table 68. Egemen International Business Overview Table 69. Egemen International Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Egemen International Contraceptive Drug Eluting Devices Product Portfolio Table 71. Egemen International Recent Development Table 72. ERENLER MEDIKAL Company Information Table 73. ERENLER MEDIKAL Business Overview Table 74. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio Table 76. ERENLER MEDIKAL Recent Development Table 77. Gyneas Company Information Table 78. Gyneas Business Overview Table 79. Gyneas Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Gyneas Contraceptive Drug Eluting Devices Product Portfolio Table 81. Gyneas Recent Development Table 82. Laboratoire CCD Company Information Table 83. Laboratoire CCD Business Overview Table 84. Laboratoire CCD Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio Table 86. Laboratoire CCD Recent Development Table 87. Medical Engineering Corporation Company Information Table 88. Medical Engineering Corporation Business Overview Table 89. Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio Table 91. Medical Engineering Corporation Recent Development Table 92. Melbea Company Information Table 93. Melbea Business Overview Table 94. Melbea Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Melbea Contraceptive Drug Eluting Devices Product Portfolio Table 96. Melbea Recent Development Table 97. Meril Life Sciences Company Information Table 98. Meril Life Sciences Business Overview Table 99. Meril Life Sciences Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio Table 101. Meril Life Sciences Recent Development Table 102. Mona Lisa Company Information Table 103. Mona Lisa Business Overview Table 104. Mona Lisa Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio Table 106. Mona Lisa Recent Development Table 107. Pregna Company Information Table 108. Pregna Business Overview Table 109. Pregna Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Pregna Contraceptive Drug Eluting Devices Product Portfolio Table 111. Pregna Recent Development Table 112. Pregna International Company Information Table 113. Pregna International Business Overview Table 114. Pregna International Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Pregna International Contraceptive Drug Eluting Devices Product Portfolio Table 116. Pregna International Recent Development Table 117. Prosan International Company Information Table 118. Prosan International Business Overview Table 119. Prosan International Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Prosan International Contraceptive Drug Eluting Devices Product Portfolio Table 121. Prosan International Recent Development Table 122. Rongbo Medical Company Information Table 123. Rongbo Medical Business Overview Table 124. Rongbo Medical Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio Table 126. Rongbo Medical Recent Development Table 127. SMB Corporation of India Company Information Table 128. SMB Corporation of India Business Overview Table 129. SMB Corporation of India Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio Table 131. SMB Corporation of India Recent Development Table 132. AbbVie Company Information Table 133. AbbVie Business Overview Table 134. AbbVie Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. AbbVie Contraceptive Drug Eluting Devices Product Portfolio Table 136. AbbVie Recent Development Table 137. Bayer Company Information Table 138. Bayer Business Overview Table 139. Bayer Contraceptive Drug Eluting Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Bayer Contraceptive Drug Eluting Devices Product Portfolio Table 141. Bayer Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Contraceptive Drug Eluting Devices Distributors List Table 145. Contraceptive Drug Eluting Devices Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Contraceptive Drug Eluting Devices Product Image Figure 2. Global Contraceptive Drug Eluting Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Drug Eluting Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Drug Eluting Devices Sales (2021-2032) & (K Units) Figure 5. Global Contraceptive Drug Eluting Devices Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Contraceptive Drug Eluting Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Non-biodegradable Image Figure 9. Biodegradable Image Figure 10. Global Contraceptive Drug Eluting Devices Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Contraceptive Drug Eluting Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2032) Figure 13. Global Contraceptive Drug Eluting Devices Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Contraceptive Drug Eluting Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2032) Figure 16. Subcutaneously Image Figure 17. Uterus Image Figure 18. Global Contraceptive Drug Eluting Devices Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Contraceptive Drug Eluting Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2032) Figure 21. Global Contraceptive Drug Eluting Devices Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Contraceptive Drug Eluting Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2032) Figure 24. North America Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 26. U.S. Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 31. Germany Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 38. China Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 46. Brazil Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Contraceptive Drug Eluting Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Contraceptive Drug Eluting Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 57. North America Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 59. Europe Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Contraceptive Drug Eluting Devices Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Contraceptive Drug Eluting Devices Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Non-biodegradable
  • Biodegradable
Applications
  • Subcutaneously
  • Uterus
Companies covered
  • CooperSurgical
  • Egemen International
  • ERENLER MEDIKAL
  • Gyneas
  • Laboratoire CCD
  • Medical Engineering Corporation
  • Melbea
  • Meril Life Sciences
  • Mona Lisa
  • Pregna
  • Pregna International
  • Prosan International
  • Rongbo Medical
  • SMB Corporation of India
  • AbbVie
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Contraceptive Drug Eluting Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Contraceptive Drug Eluting Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Contraceptive Drug Eluting Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Contraceptive Drug Eluting Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Contraceptive Drug Eluting Devices Market Dynamics
  1. 2.1 Contraceptive Drug Eluting Devices Industry Trends
  2. 2.2 Contraceptive Drug Eluting Devices Industry Drivers
  3. 2.3 Contraceptive Drug Eluting Devices Industry Opportunities and Challenges
  4. 2.4 Contraceptive Drug Eluting Devices Industry Restraints
3 Contraceptive Drug Eluting Devices Market by Manufacturers
  1. 3.1 Global Contraceptive Drug Eluting Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Contraceptive Drug Eluting Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Contraceptive Drug Eluting Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Contraceptive Drug Eluting Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contraceptive Drug Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Contraceptive Drug Eluting Devices Manufacturers, Product Type & Application
  7. 3.7 Global Contraceptive Drug Eluting Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contraceptive Drug Eluting Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contraceptive Drug Eluting Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contraceptive Drug Eluting Devices Tier 1, Tier 2, and Tier 3
4 Contraceptive Drug Eluting Devices Market by Type
  1. 4.1 Contraceptive Drug Eluting Devices Type Introduction
  2. 4.1.1 Non-biodegradable
  3. 4.1.2 Biodegradable
  4. 4.2 Global Contraceptive Drug Eluting Devices Sales by Type
  5. 4.2.1 Global Contraceptive Drug Eluting Devices Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Contraceptive Drug Eluting Devices Sales by Type (2021-2032)
  7. 4.2.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2032)
  8. 4.3 Global Contraceptive Drug Eluting Devices Revenue by Type
  9. 4.3.1 Global Contraceptive Drug Eluting Devices Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Contraceptive Drug Eluting Devices Revenue by Type (2021-2032)
  11. 4.3.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2032)
5 Contraceptive Drug Eluting Devices Market by Application
  1. 5.1 Contraceptive Drug Eluting Devices Application Introduction
  2. 5.1.1 Subcutaneously
  3. 5.1.2 Uterus
  4. 5.2 Global Contraceptive Drug Eluting Devices Sales by Application
  5. 5.2.1 Global Contraceptive Drug Eluting Devices Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Contraceptive Drug Eluting Devices Sales by Application (2021-2032)
  7. 5.2.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2032)
  8. 5.3 Global Contraceptive Drug Eluting Devices Revenue by Application
  9. 5.3.1 Global Contraceptive Drug Eluting Devices Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Contraceptive Drug Eluting Devices Revenue by Application (2021-2032)
  11. 5.3.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2032)
6 Global Contraceptive Drug Eluting Devices Sales by Region
  1. 6.1 Global Contraceptive Drug Eluting Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptive Drug Eluting Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptive Drug Eluting Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Contraceptive Drug Eluting Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Contraceptive Drug Eluting Devices Revenue by Region
  1. 7.1 Global Contraceptive Drug Eluting Devices Revenue by Region
  2. 7.1.1 Global Contraceptive Drug Eluting Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Contraceptive Drug Eluting Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Contraceptive Drug Eluting Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Contraceptive Drug Eluting Devices Revenue (2021-2032)
  8. 7.2.2 North America Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Contraceptive Drug Eluting Devices Revenue (2021-2032)
  11. 7.3.2 Europe Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Contraceptive Drug Eluting Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Contraceptive Drug Eluting Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Contraceptive Drug Eluting Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CooperSurgical
  2. 8.1.1 CooperSurgical Company Information
  3. 8.1.2 CooperSurgical Business Overview
  4. 8.1.3 CooperSurgical Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio
  6. 8.1.5 CooperSurgical Recent Developments
  7. 8.2 Egemen International
  8. 8.2.1 Egemen International Company Information
  9. 8.2.2 Egemen International Business Overview
  10. 8.2.3 Egemen International Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Egemen International Contraceptive Drug Eluting Devices Product Portfolio
  12. 8.2.5 Egemen International Recent Developments
  13. 8.3 ERENLER MEDIKAL
  14. 8.3.1 ERENLER MEDIKAL Company Information
  15. 8.3.2 ERENLER MEDIKAL Business Overview
  16. 8.3.3 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio
  18. 8.3.5 ERENLER MEDIKAL Recent Developments
  19. 8.4 Gyneas
  20. 8.4.1 Gyneas Company Information
  21. 8.4.2 Gyneas Business Overview
  22. 8.4.3 Gyneas Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Gyneas Contraceptive Drug Eluting Devices Product Portfolio
  24. 8.4.5 Gyneas Recent Developments
  25. 8.5 Laboratoire CCD
  26. 8.5.1 Laboratoire CCD Company Information
  27. 8.5.2 Laboratoire CCD Business Overview
  28. 8.5.3 Laboratoire CCD Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio
  30. 8.5.5 Laboratoire CCD Recent Developments
  31. 8.6 Medical Engineering Corporation
  32. 8.6.1 Medical Engineering Corporation Company Information
  33. 8.6.2 Medical Engineering Corporation Business Overview
  34. 8.6.3 Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio
  36. 8.6.5 Medical Engineering Corporation Recent Developments
  37. 8.7 Melbea
  38. 8.7.1 Melbea Company Information
  39. 8.7.2 Melbea Business Overview
  40. 8.7.3 Melbea Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Melbea Contraceptive Drug Eluting Devices Product Portfolio
  42. 8.7.5 Melbea Recent Developments
  43. 8.8 Meril Life Sciences
  44. 8.8.1 Meril Life Sciences Company Information
  45. 8.8.2 Meril Life Sciences Business Overview
  46. 8.8.3 Meril Life Sciences Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio
  48. 8.8.5 Meril Life Sciences Recent Developments
  49. 8.9 Mona Lisa
  50. 8.9.1 Mona Lisa Company Information
  51. 8.9.2 Mona Lisa Business Overview
  52. 8.9.3 Mona Lisa Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio
  54. 8.9.5 Mona Lisa Recent Developments
  55. 8.10 Pregna
  56. 8.10.1 Pregna Company Information
  57. 8.10.2 Pregna Business Overview
  58. 8.10.3 Pregna Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pregna Contraceptive Drug Eluting Devices Product Portfolio
  60. 8.10.5 Pregna Recent Developments
  61. 8.11 Pregna International
  62. 8.11.1 Pregna International Company Information
  63. 8.11.2 Pregna International Business Overview
  64. 8.11.3 Pregna International Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pregna International Contraceptive Drug Eluting Devices Product Portfolio
  66. 8.11.5 Pregna International Recent Developments
  67. 8.12 Prosan International
  68. 8.12.1 Prosan International Company Information
  69. 8.12.2 Prosan International Business Overview
  70. 8.12.3 Prosan International Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Prosan International Contraceptive Drug Eluting Devices Product Portfolio
  72. 8.12.5 Prosan International Recent Developments
  73. 8.13 Rongbo Medical
  74. 8.13.1 Rongbo Medical Company Information
  75. 8.13.2 Rongbo Medical Business Overview
  76. 8.13.3 Rongbo Medical Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio
  78. 8.13.5 Rongbo Medical Recent Developments
  79. 8.14 SMB Corporation of India
  80. 8.14.1 SMB Corporation of India Company Information
  81. 8.14.2 SMB Corporation of India Business Overview
  82. 8.14.3 SMB Corporation of India Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio
  84. 8.14.5 SMB Corporation of India Recent Developments
  85. 8.15 AbbVie
  86. 8.15.1 AbbVie Company Information
  87. 8.15.2 AbbVie Business Overview
  88. 8.15.3 AbbVie Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AbbVie Contraceptive Drug Eluting Devices Product Portfolio
  90. 8.15.5 AbbVie Recent Developments
  91. 8.16 Bayer
  92. 8.16.1 Bayer Company Information
  93. 8.16.2 Bayer Business Overview
  94. 8.16.3 Bayer Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bayer Contraceptive Drug Eluting Devices Product Portfolio
  96. 8.16.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptive Drug Eluting Devices Value Chain Analysis
  2. 9.1.1 Contraceptive Drug Eluting Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptive Drug Eluting Devices Production Mode & Process
  6. 9.2 Contraceptive Drug Eluting Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptive Drug Eluting Devices Distributors
  9. 9.2.3 Contraceptive Drug Eluting Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst